DA
DCF Advisers Portfolio holdings
AUM
$208M
This Quarter Return
+7.18%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$129M
AUM Growth
+$129M
(-4.4%)
Cap. Flow
-$13.7M
Cap. Flow
% of AUM
-10.57%
Top 10 Holdings %
Top 10 Hldgs %
57.47%
Holding
75
New
7
Increased
13
Reduced
23
Closed
9
Top Buys
| 1 |
Bank of America
BAC
|
$2.98M |
| 2 |
VanEck Junior Gold Miners ETF
GDXJ
|
$1.6M |
| 3 |
Nuveen Credit Strategies Income Fund
JQC
|
$786K |
| 4 |
Vir Biotechnology
VIR
|
$607K |
| 5 |
Alibaba
BABA
|
$573K |
Top Sells
| 1 |
Citigroup
C
|
$2.94M |
| 2 |
VanEck Gold Miners ETF
GDX
|
$2.47M |
| 3 |
Altimmune
ALT
|
$2.44M |
| 4 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$2.39M |
| 5 |
Apple
AAPL
|
$1.62M |
Sector Composition
| 1 | Healthcare | 48.44% |
| 2 | Technology | 14.47% |
| 3 | Communication Services | 8.83% |
| 4 | Financials | 7.09% |
| 5 | Energy | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
AbbVie
ABBV
$372B
| $11.6M | 7.86% | 72,000 -4,100 | -5% | -$663K |
|
2
argenx
ARGX
$43.6B
| $9.47M | 6.4% | 25,000 | – | – |
|
|
ITCI
3
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $8.27M | 5.59% | 156,250 -9,749 | -6% | -$516K |
|
|
4
Bank of America
BAC
$376B
| $7.95M | 5.37% | 240,000 +90,000 | +60% | +$2.98M |
|
5
Regeneron Pharmaceuticals
REGN
$61.5B
| $7.86M | 5.31% | 10,900 -150 | -1% | -$108K |
|
6
Micron Technology
MU
$133B
| $7.75M | 5.24% | 155,000 -20,000 | -11% | -$1,000K |
|
7
Alphabet (Google) Class C
GOOG
$2.58T
| $7.28M | 4.92% | 82,000 +2,000 | +3% | +$177K |
|
8
Xencor
XNCR
$580M
| $5.36M | 3.62% | 205,973 -25,827 | -11% | -$673K |
|
9
Prothena Corp
PRTA
$441M
| $4.46M | 3.02% | 74,100 +6,100 | +9% | +$368K |
|
10
Energy Transfer Partners
ET
$60.8B
| $4.36M | 2.95% | 367,500 +7,500 | +2% | +$89K |
|
11
SPDR Gold Trust
GLD
$107B
| $4.07M | 2.75% | 24,000 +1,500 | +7% | +$254K |
|
12
Incyte
INCY
$16.5B
| $3.53M | 2.39% | 44,000 | – | – |
|
13
Oracle
ORCL
$635B
| $3.51M | 2.38% | 43,000 +4,000 | +10% | +$327K |
|
14
iShares Gold Trust
IAU
$50.6B
| $3.46M | 2.34% | 100,000 | – | – |
|
15
Eli Lilly
LLY
$657B
| $3.02M | 2.04% | 8,250 | – | – |
|
16
AT&T
T
$209B
| $2.62M | 1.77% | 142,500 -52,500 | -27% | -$967K |
|
|
AOD
17
abrdn Total Dynamic Dividend Fund
AOD
$963M
| $2.12M | 1.43% | 272,000 | – | – |
|
18
Advanced Micro Devices
AMD
$264B
| $1.94M | 1.31% | 30,000 | – | – |
|
|
19
Apple
AAPL
$3.45T
| $1.92M | 1.3% | 14,750 -12,500 | -46% | -$1.62M |
|
20
Pfizer
PFE
$141B
| $1.86M | 1.26% | 36,250 | – | – |
|
21
Turning Point Brands
TPB
$1.79B
| $1.8M | 1.22% | 83,113 -1,723 | -2% | -$37.3K |
|
|
22
VanEck Junior Gold Miners ETF
GDXJ
$6.6B
| $1.6M | 1.08% | +45,000 | New | +$1.6M |
|
|
SGEN
23
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.6M | 1.08% | 12,450 +700 | +6% | +$90K |
|
|
24
Nuveen Credit Strategies Income Fund
JQC
$754M
| $1.59M | 1.07% | 311,420 +154,420 | +98% | +$786K |
|
25
General Motors
GM
$55.8B
| $1.48M | 1% | 44,000 | – | – |
|